← Back to Search

Liquid Embolic Agent

PHIL® Liquid Embolic System for Arteriovenous Malformations (PHIL dAVF Trial)

N/A
Waitlist Available
Led By J Mocco, MD
Research Sponsored by Microvention-Terumo, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group

Summary

This trial uses a special liquid to treat patients with abnormal blood vessel connections in the brain, who have few safe treatment options. The liquid hardens and blocks these abnormal vessels, stopping the problematic blood flow.

Eligible Conditions
  • Arteriovenous Malformations

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Subjects with neurological death or ipsilateral stroke
Secondary study objectives
Technical events during the PHIL embolization procedure(s)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: dAVF treatmentExperimental Treatment1 Intervention
PHIL® Liquid Embolic System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PHIL® Liquid Embolic System
2018
N/A
~70

Find a Location

Who is running the clinical trial?

Microvention-Terumo, Inc.Lead Sponsor
31 Previous Clinical Trials
6,937 Total Patients Enrolled
1 Trials studying Arteriovenous Malformations
20 Patients Enrolled for Arteriovenous Malformations
J Mocco, MDPrincipal InvestigatorMt. Sinai
4 Previous Clinical Trials
1,275 Total Patients Enrolled
Alan Boulos, MDPrincipal InvestigatorAlbany Medical College
~9 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top